G Engström1, B Hedblad, L Janzon, F Lindgärde. 1. Department of Clinical Sciences MFC Ing 59 Lund University, Malmö University Hospital, S-20502, Malmö, Sweden. Gunnar.Engstrom@med.lu.se
Abstract
AIMS/HYPOTHESIS: Mice that are deficient for complement factor 3 (C3) have shown resistance to weight gain, despite increased food intake. Cross-sectional studies of humans have reported correlations between C3 and obesity. This longitudinal study explored whether C3 predicts a large weight gain in middle-aged men. METHODS: Plasma concentrations of C3 and complement factor 4 (C4) were measured in 2,706 non-diabetic healthy men aged between 38 and 50 years, who were re-examined after a mean period of 6.1 years. RESULTS: After adjustments for initial weight, age, height and follow-up time, the odds of incurring large weight gain (75th percentile, > or =3.8 kg) were 1.00 (reference), 0.96 (95% CI:0.7-1.2), 1.1 (CI:0.9-1.5) and 1.4 (CI:1.1-1.8), respectively, among men with C3 levels in the first, second, third and fourth quartiles (p for trend=0.01) respectively. This relationship remained significant after further adjustments for lifestyle factors (physical inactivity, alcohol, smoking), metabolic factors (glucose or homeostasis model assessment values, cholesterol, triglycerides), inflammatory markers (fibrinogen, haptoglobin, ceruloplasmin, orosomucoid, alpha1-antitrypsin) and for C4. C4 was associated with weight gain after adjustments for initial weight, height, follow-up time and lifestyle factors, but not after adjustments for C3. CONCLUSIONS/ INTERPRETATION: C3 is a risk factor for incurring large weight gain in middle-aged men.
AIMS/HYPOTHESIS: Mice that are deficient for complement factor 3 (C3) have shown resistance to weight gain, despite increased food intake. Cross-sectional studies of humans have reported correlations between C3 and obesity. This longitudinal study explored whether C3 predicts a large weight gain in middle-aged men. METHODS: Plasma concentrations of C3 and complement factor 4 (C4) were measured in 2,706 non-diabetic healthy men aged between 38 and 50 years, who were re-examined after a mean period of 6.1 years. RESULTS: After adjustments for initial weight, age, height and follow-up time, the odds of incurring large weight gain (75th percentile, > or =3.8 kg) were 1.00 (reference), 0.96 (95% CI:0.7-1.2), 1.1 (CI:0.9-1.5) and 1.4 (CI:1.1-1.8), respectively, among men with C3 levels in the first, second, third and fourth quartiles (p for trend=0.01) respectively. This relationship remained significant after further adjustments for lifestyle factors (physical inactivity, alcohol, smoking), metabolic factors (glucose or homeostasis model assessment values, cholesterol, triglycerides), inflammatory markers (fibrinogen, haptoglobin, ceruloplasmin, orosomucoid, alpha1-antitrypsin) and for C4. C4 was associated with weight gain after adjustments for initial weight, height, follow-up time and lifestyle factors, but not after adjustments for C3. CONCLUSIONS/ INTERPRETATION:C3 is a risk factor for incurring large weight gain in middle-aged men.
Authors: C J Halkes; H van Dijk; P P de Jaegere; H W Plokker; Y van Der Helm; D W Erkelens; M Castro Cabezas Journal: Arterioscler Thromb Vasc Biol Date: 2001-09 Impact factor: 8.311
Authors: V Van Harmelen; S Reynisdottir; K Cianflone; E Degerman; J Hoffstedt; K Nilsell; A Sniderman; P Arner Journal: J Biol Chem Date: 1999-06-25 Impact factor: 5.157
Authors: Gunnar Engström; Bo Hedblad; Lars Stavenow; Susanna Jonsson; Peter Lind; Lars Janzon; Folke Lindgärde Journal: Arterioscler Thromb Vasc Biol Date: 2004-06-03 Impact factor: 8.311
Authors: Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus Journal: Immunol Res Date: 2016-06 Impact factor: 2.829
Authors: M M J van Greevenbroek; S Ghosh; C J H van der Kallen; M C G J Brouwers; C G Schalkwijk; C D A Stehouwer Journal: J Clin Endocrinol Metab Date: 2012-10-09 Impact factor: 5.958